UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055589 |
|---|---|
| Receipt number | R000063525 |
| Scientific Title | Disaster Eye Navi |
| Date of disclosure of the study information | 2024/10/01 |
| Last modified on | 2025/07/28 07:53:27 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evacuation training by able-bodied volunteers using Disaster Eye Navi (D-Eye Navi), a sensory information conversion application that escorts people with disabilities from immediately after a disaster to life in an evacuation center.
Acronym
Disaster Eye Navi
Scientific Title
Disaster Eye Navi
Scientific Title:Acronym
Disaster Eye Navi
Region
| Japan |
Condition
Condition
Simulated visually impaired person
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This time, the Eye Navi will be used by able-bodied volunteer students to provide guidance and assistance in the event of a disaster while on the way to or from campus, as well as to assist in the use of the Eye Navi in evacuation shelters. In addition to expanding to other university campuses, this will help support disaster preparedness for the visually impaired at event sites (Osaka Expo and Disneyland), which are requested by support groups for the visually impaired.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
not applicable
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 30 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patients who are between 18 and 30 years of age at the time of consent.
Key exclusion criteria
1) Persons with any kind of functional disability
2) Other persons deemed unsuitable by the principal investigator
Target sample size
3
Research contact person
Name of lead principal investigator
| 1st name | Takeshi |
| Middle name | |
| Last name | Sugawara |
Organization
Chiba University Hospial
Division name
Ophthalmology
Zip code
2630024
Address
Chiba City, Chuo-ku, Inohana 1-8-1
TEL
0432262484
takeshis@faculty.chiba-u.jp
Public contact
Name of contact person
| 1st name | Takeshi |
| Middle name | |
| Last name | Sugawara |
Organization
Chiba University Hospital
Division name
Ophthalmology
Zip code
2630024
Address
Chiba City, Chuo-ku, Inohana 1-8-1
TEL
0432262484
Homepage URL
takeshis@faculty.chiba-u.jp
Sponsor or person
Institute
Chiba University Hospital
Institute
Department
Personal name
Funding Source
Organization
NON
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Chiba University Hospital
Address
Chiba City, Chuo-ku, Inohana 1-8-1
Tel
0432227171
takeshis@faculty.chiba-u.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 09 | Month | 05 | Day |
Date of IRB
| 2024 | Year | 09 | Month | 05 | Day |
Anticipated trial start date
| 2024 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
NA
Management information
Registered date
| 2024 | Year | 09 | Month | 23 | Day |
Last modified on
| 2025 | Year | 07 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063525
